RESEARCHER PROFILE

А. С. Колбин

← Back to St Petersburg University

А

St Petersburg University

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyAntibiotic Use and ResistanceMedical and Pharmaceutic StudiesPharmacovigilance and Adverse Drug Reactions

А. С. Колбин works in Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Antibiotic Use and Resistance, Medical and Pharmaceutic Studies, Pharmacovigilance and Adverse Drug Reactions. Recorded institutional associations include St Petersburg University, First Pavlov State Medical University of St. Petersburg.

401Publications
612Citations
9H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia

    2014 · 44 citations
  2. A mathematical model for predicting the development of bacterial resistance based on the relationship between the level of antimicrobial resistance and the volume of antibiotic consumption

    2017 · 43 citations
  3. Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2)

    2016 · 29 citations
  4. Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

    2018 · 24 citations
  5. MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)

    2017 · 16 citations
  6. Review of real-world data study

    2021 · 15 citations
  7. Socioeconomic and global burden of COVID-19

    2021 · 14 citations
  8. Retrospective surveillance of antibiotic use in maternity wards and neonatal intensive care units in Saint Petersburg, Russia

    2018 · 10 citations
  9. EPIDEMIOLOGICAL, CLINICAL AND FINANCIAL COMPONENTS OF RESULTS OF LONGTERM ANTIRETROVIRAL THERAPY OF PATIENTS WITH HIVINFECTION

    2020 · 10 citations
  10. Socio-economic burden of COVID-19 in the Russian Federation

    2020 · 9 citations
  11. «DIARISK» — the first national prediabetes and diabetes mellitus type 2 risk calculator

    2021 · 9 citations
  12. A brief report of real-world evidence development (RWD/RWE) in 2021: United States, Russia, and the Eurasian Economic Union (EAEU)

    2022 · 9 citations
  13. What should be considered if you decide to build your own mathematical model for predicting the development of bacterial resistance? Recommendations based on a systematic review of the literature

    2015 · 8 citations
  14. Система фармаконадзора в Евразийском экономическом союзе

    2018 · 8 citations
  15. The social-economic burden of spinal muscular atrophy in Russia

    2021 · 8 citations
  16. COMPARATIVE REVIEW OF METHODOLOGIES FOR ESTIMATING THE COST OF ADVERSE DRUG REACTIONS IN THE RUSSIAN FEDERATION AND BRAZIL

    2021 · 8 citations
  17. Resolution based on the results of the conference: "RWD/ RWE – Research Tools of Real-World Clinical Practice Today and Tomorrow"

    2021 · 8 citations
  18. Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study

    2022 · 8 citations
  19. Invasive aspergillosis: results of multicenter study

    2014 · 7 citations
  20. COVID-19 and clinical pharmacology

    2020 · 7 citations
  21. Nonsteroidal anti-inflammatory drugs’ adverse drug reactions: 10 years of national database data

    2022 · 7 citations
  22. The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies

    2022 · 7 citations
  23. Antimicrobial drug consumption in the Russian Federation (2008–2022): pharmacoepidemiological study

    2023 · 7 citations
  24. Improving data retrieval quality: Evidence based medicine perspective

    2015 · 6 citations
  25. Quantitative and qualitative evaluation of the use of nonsteroidal anti-inflammatory drugs in the Russian Federation over 10 years

    2022 · 6 citations

← Return to the university profile